Informed-money record

LRMR · Larimar Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$250.7M / $0

Recent disclosures

25 of 46 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-07-06	Director Hamilton Thomas Edward	bought	$167K	SEC ↗
2026-02-27	Director SHERMAN JEFFREY W	bought	$25K	SEC ↗
2026-02-27	Director THOMAS FRANK E	bought	$25K	SEC ↗
2026-02-27	Director Hamilton Thomas Edward	bought	$500K	SEC ↗
2026-02-27	Director Deerfield Mgmt IV, L.P.	bought	$5.4M	SEC ↗

21 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Start free — 1 week, no card →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals